Qiyuan Zhuang

Qiyuan Zhuang

Auto-generated profile, based on publicly available information

Qiyuan Zhuang

Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, P. R. China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2020 in Laboratory Investigation
Verified
Journal Article
Open access
PDF file
QZQiyuan Zhuang
Qiyuan Zhuang
Li FangLi Fang
Li Fang
JLJun Liu
Jun Liu
HWHongyu Wang
Hongyu Wang
YTYuchen Tian
Yuchen Tian
WHWu Huijuan
Wu Huijuan
Focal segmental glomerulosclerosis (FSGS) is a chronic glomerular disease with poor clinical outcomes. Podocyte loss via apoptosis is one important mechanism underlying the pathogenesis of FSGS. Recently, Yes-associated-protein (YAP), a key downstream protein in the Hippo pathway, was identified as an activator for multiple gene transcriptional factors in the nucleus to control cell proliferation and apoptosis. To investigate the potential role of YAP in the progression of FSGS, we examined kidney samples from patients with minimal change disease or FSGS and found that increases in podocyte apoptosis is positively correlated with the cytoplasmic distribution of YAP in human FSGS. Utilizing an established mT/mG transgenic mouse model and primary cultured podocytes, we found that YAP was distributed uniformly in nucleus and cytoplasm in the podocytes of control animals. Adriamycin treatment induced gradual nuclear exclusion of YAP with enhanced phospho-YAP/YAP ratio, accompanied by the induction of podocyte apoptosis both in vivo and in vitro. Moreover, we used verteporfin to treat an Adriamycin-induced FSGS mouse model, and found YAP inhibition by verteporfin induced nuclear exclusion of YAP, thus increasing podocyte apoptosis and accelerating disease progression. Therefore, our findings suggest that YAP nuclear distribution and activation in podocytes is an important endogenous anti-apoptotic mechanism during the progression of FSGS.

22 August 2020 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
HLHuigao Luo
Huigao Luo
QZQiyuan Zhuang
Qiyuan Zhuang
YWYuanyuan Wang
Yuanyuan Wang
AAAibaidula Abudumijiti
Aibaidula Abudumijiti
KSKuangyu Shi
Kuangyu Shi
ZSZhifeng Shi
Zhifeng Shi

4 November 2025 in Nature Aging
Verified
Journal Article
Open access
PDF file
QZQiyuan Zhuang
Qiyuan Zhuang
YHYihan Hu
Yihan Hu
DWDang Wei
Dang Wei
CQChenxi Qin
Chenxi Qin
KHKejia Hu
Kejia Hu
FFFang Fang
Fang Fang
Infectious diseases are known to trigger acute seizures, but their long-term impact on epilepsy, especially in later life, is unclear. We conducted nested case–control studies of newly diagnosed epilepsy after age 50 in the UK Biobank (2,486 cases; 12,430 controls) and Swedish registers (56,266 cases; 281,330 controls), including a sibling comparison. Previous hospital-treated infections were associated with a persistently elevated epilepsy risk (for example, >10 years after infection: odds ratio (OR) 1.68, 95% confidence interval: 1.39–2.04 in UK Biobank; 1.46, 1.41–1.51 in Sweden). Associations were robust in sibling analyses and across infection types and sites. We further found that infections, together with a high cardiovascular genetic risk (OR 2.62, 2.22–3.08), a high cardiovascular risk score (OR 3.14, 2.68–3.68) or cardiovascular disease history (OR 4.77, 4.64–4.91), were associated with the highest epilepsy risk. Hospital-treated infections exert prolonged impact on epilepsy risk in older age, especially when in combination with cardiovascular risk factors.